Literature DB >> 20875418

Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.

Arthur Y Kim1, Thomas Kuntzen, Joerg Timm, Brian E Nolan, Melanie A Baca, Laura L Reyor, Andrew C Berical, Andrea J Feller, Kristin L Johnson, Julian Schulze zur Wiesch, Gregory K Robbins, Raymond T Chung, Bruce D Walker, Mary Carrington, Todd M Allen, Georg M Lauer.   

Abstract

BACKGROUND & AIMS: HLA class I alleles are linked to spontaneous control of hepatitis C virus (HCV) and human immunodeficiency virus-1, but for HCV the roles of particular alleles and corresponding CD8(+) T-cell responses remain incompletely defined. We aimed to determine the correlations between these alleles and natural outcomes of HCV and determine associated key T-cell responses.
METHODS: In a cohort of HCV individuals, we determined HLA class I alleles, HCV outcomes, T-cell responses, and examined sequence data for mutational changes within key epitopes.
RESULTS: Carriage of HLA-B 57 was associated with a higher rate of viral clearance (risk ratio = 2.0; 95% confidence interval: 1.2-3.4), while HLA-B 08 was associated with a lower rate (risk ratio = 0.34; 95% confidence interval: 0.1-0.9]. Two HLA-B 57-restricted T-cell epitopes were targeted in spontaneous clearance; subjects with chronic viremia expressing HLA-B 57 harbored HCV strains with a high frequency of mutations in key residues. HLA-B 57-mediated escape was supported by diminished immune recognition of these variants and acute HCV infection revealing viral evolution toward less recognized variants. Analysis of a genotype 1b strain from a single-source HCV outbreak in which HLA-B 57 was not protective revealed sequence variations that interfere with immunogenicity, thereby preventing HLA-B 57-mediated immune pressure.
CONCLUSIONS: Our data indicate a role of HLA-B 57-restricted CD8(+) T-cell responses in mediating spontaneous clearance and evolution in HCV infection, and viral strains containing epitope variants that are less recognized abrogate the protective effects of HLA-B 57. The finding that HLA-B 57-mediated antiviral immunity is associated with control of both human immunodeficiency virus-1 and HCV suggests a common shared mechanism of a successful immune response against persistent viruses.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20875418      PMCID: PMC3021586          DOI: 10.1053/j.gastro.2010.09.042

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  32 in total

1.  Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia.

Authors:  Mark H Kuniholm; Andrea Kovacs; Xiaojiang Gao; Xiaonan Xue; Darlene Marti; Chloe L Thio; Marion G Peters; Norah A Terrault; Ruth M Greenblatt; James J Goedert; Mardge H Cohen; Howard Minkoff; Stephen J Gange; Kathryn Anastos; Melissa Fazzari; Tiffany G Harris; Mary A Young; Howard D Strickler; Mary Carrington
Journal:  Hepatology       Date:  2010-05       Impact factor: 17.425

2.  Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.

Authors:  Florencia Pereyra; Marylyn M Addo; Daniel E Kaufmann; Yang Liu; Toshiyuki Miura; Almas Rathod; Brett Baker; Alicja Trocha; Rachel Rosenberg; Elizabeth Mackey; Peggy Ueda; Zhigang Lu; Daniel Cohen; Terri Wrin; Christos J Petropoulos; Eric S Rosenberg; Bruce D Walker
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

Review 3.  Host genetic determinants of spontaneous hepatitis C clearance.

Authors:  Andri Rauch; Silvana Gaudieri; Chloe Thio; Pierre-Yves Bochud
Journal:  Pharmacogenomics       Date:  2009-11       Impact factor: 2.533

4.  Portable flanking sequences modulate CTL epitope processing.

Authors:  Sylvie Le Gall; Pamela Stamegna; Bruce D Walker
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

5.  Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution.

Authors:  Joerg Timm; Bin Li; Marcus G Daniels; Tanmoy Bhattacharya; Laura L Reyor; Rachel Allgaier; Thomas Kuntzen; Will Fischer; Brian E Nolan; Jared Duncan; Julian Schulze zur Wiesch; Arthur Y Kim; Nicole Frahm; Christian Brander; Raymond T Chung; Georg M Lauer; Bette T Korber; Todd M Allen
Journal:  Hepatology       Date:  2007-08       Impact factor: 17.425

6.  Adaptation of HIV-1 to human leukocyte antigen class I.

Authors:  Yuka Kawashima; Katja Pfafferott; John Frater; Philippa Matthews; Rebecca Payne; Marylyn Addo; Hiroyuki Gatanaga; Mamoru Fujiwara; Atsuko Hachiya; Hirokazu Koizumi; Nozomi Kuse; Shinichi Oka; Anna Duda; Andrew Prendergast; Hayley Crawford; Alasdair Leslie; Zabrina Brumme; Chanson Brumme; Todd Allen; Christian Brander; Richard Kaslow; James Tang; Eric Hunter; Susan Allen; Joseph Mulenga; Songee Branch; Tim Roach; Mina John; Simon Mallal; Anthony Ogwu; Roger Shapiro; Julia G Prado; Sarah Fidler; Jonathan Weber; Oliver G Pybus; Paul Klenerman; Thumbi Ndung'u; Rodney Phillips; David Heckerman; P Richard Harrigan; Bruce D Walker; Masafumi Takiguchi; Philip Goulder
Journal:  Nature       Date:  2009-02-25       Impact factor: 49.962

7.  Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype-specific immunodominant CD8+ T-cell epitope.

Authors:  Christoph Neumann-Haefelin; Jörg Timm; Julia Schmidt; Nadine Kersting; Karen Fitzmaurice; Cesar Oniangue-Ndza; Michael N Kemper; Isla Humphreys; Susan McKiernan; Dermot Kelleher; Volker Lohmann; Paul Bowness; Daniela Huzly; Hugo R Rosen; Arthur Y Kim; Georg M Lauer; Todd M Allen; Eleanor Barnes; Michael Roggendorf; Hubert E Blum; Robert Thimme
Journal:  Hepatology       Date:  2010-01       Impact factor: 17.425

8.  Evolution of HLA-B*5703 HIV-1 escape mutations in HLA-B*5703-positive individuals and their transmission recipients.

Authors:  Hayley Crawford; Wendy Lumm; Alasdair Leslie; Malinda Schaefer; Debrah Boeras; Julia G Prado; Jianming Tang; Paul Farmer; Thumbi Ndung'u; Shabir Lakhi; Jill Gilmour; Paul Goepfert; Bruce D Walker; Richard Kaslow; Joseph Mulenga; Susan Allen; Philip J R Goulder; Eric Hunter
Journal:  J Exp Med       Date:  2009-03-23       Impact factor: 14.307

9.  A whole-genome association study of major determinants for host control of HIV-1.

Authors:  Jacques Fellay; Kevin V Shianna; Dongliang Ge; Sara Colombo; Bruno Ledergerber; Mike Weale; Kunlin Zhang; Curtis Gumbs; Antonella Castagna; Andrea Cossarizza; Alessandro Cozzi-Lepri; Andrea De Luca; Philippa Easterbrook; Patrick Francioli; Simon Mallal; Javier Martinez-Picado; José M Miro; Niels Obel; Jason P Smith; Josiane Wyniger; Patrick Descombes; Stylianos E Antonarakis; Norman L Letvin; Andrew J McMichael; Barton F Haynes; Amalio Telenti; David B Goldstein
Journal:  Science       Date:  2007-07-19       Impact factor: 47.728

10.  Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response.

Authors:  Eva Dazert; Christoph Neumann-Haefelin; Stéphane Bressanelli; Karen Fitzmaurice; Julia Kort; Jörg Timm; Susan McKiernan; Dermot Kelleher; Norbert Gruener; John E Tavis; Hugo R Rosen; Jaqueline Shaw; Paul Bowness; Hubert E Blum; Paul Klenerman; Ralf Bartenschlager; Robert Thimme
Journal:  J Clin Invest       Date:  2009-01-12       Impact factor: 14.808

View more
  67 in total

1.  Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.

Authors:  Andreas Walker; Kathrin Skibbe; Eike Steinmann; Stephanie Pfaender; Thomas Kuntzen; Dominik A Megger; Svenja Groten; Barbara Sitek; Georg M Lauer; Arthur Y Kim; Thomas Pietschmann; Todd M Allen; Joerg Timm
Journal:  J Virol       Date:  2015-10-07       Impact factor: 5.103

Review 2.  Update on hepatitis C virus-specific immunity.

Authors:  Donatella Ciuffreda; Arthur Y Kim
Journal:  Curr Opin HIV AIDS       Date:  2011-11       Impact factor: 4.283

Review 3.  Pathogenesis of chronic viral hepatitis: differential roles of T cells and NK cells.

Authors:  Barbara Rehermann
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

4.  Statistical linkage analysis of substitutions in patient-derived sequences of genotype 1a hepatitis C virus nonstructural protein 3 exposes targets for immunogen design.

Authors:  Ahmed A Quadeer; Raymond H Y Louie; Karthik Shekhar; Arup K Chakraborty; I-Ming Hsing; Matthew R McKay
Journal:  J Virol       Date:  2014-04-23       Impact factor: 5.103

5.  A closer look at hepatitis C clearance in HIV controllers: a response.

Authors:  Alice K Asher; Glenn-Milo Santos; Jennifer Evans; E Kainne Dokubo; Tzong-Hae Lee; Jeffrey N Martin; Steven G Deeks; Leslie H Tobler; Michael Busch; Peter W Hunt; Kimbely Page
Journal:  AIDS       Date:  2014-05-15       Impact factor: 4.177

6.  HLA-B18 as a risk factor of short-term progression to severe liver fibrosis in HIV/HCV co-infected patients with absent or minimal fibrosis: implications for timing of therapy.

Authors:  M Frías; D Rodríguez-Cano; F Cuenca-López; J Macías; A Gordon; B Manzanares-Martín; J A Pineda; Á Camacho; J Torre-Cisneros; J Peña; A Rivero-Juárez; A Rivero
Journal:  Pharmacogenomics J       Date:  2016-05-31       Impact factor: 3.550

7.  Early HLA-B*57-restricted CD8+ T lymphocyte responses predict HIV-1 disease progression.

Authors:  Catherine A Brennan; F Javier Ibarrondo; Catherine A Sugar; Mary Ann Hausner; Roger Shih; Hwee L Ng; Roger Detels; Joseph B Margolick; Charles R Rinaldo; John Phair; Lisa P Jacobson; Otto O Yang; Beth D Jamieson
Journal:  J Virol       Date:  2012-07-18       Impact factor: 5.103

8.  Genotype imputation performance of three reference panels using African ancestry individuals.

Authors:  Candelaria Vergara; Margaret M Parker; Liliana Franco; Michael H Cho; Ana V Valencia-Duarte; Terri H Beaty; Priya Duggal
Journal:  Hum Genet       Date:  2018-04-10       Impact factor: 4.132

Review 9.  HIV controllers: a multifactorial phenotype of spontaneous viral suppression.

Authors:  Jacques Thèze; Lisa A Chakrabarti; Benoît Vingert; Filippos Porichis; Daniel E Kaufmann
Journal:  Clin Immunol       Date:  2011-08-04       Impact factor: 3.969

10.  Synergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infection.

Authors:  Shirin Ashraf; Katja Nitschke; Usama M Warshow; Collin R Brooks; Arthur Y Kim; Georg M Lauer; Theresa J Hydes; Matthew E Cramp; Graeme Alexander; Ann-Margaret Little; Robert Thimme; Christoph Neumann-Haefelin; Salim I Khakoo
Journal:  Hepatology       Date:  2013-07-29       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.